322 related articles for article (PubMed ID: 16442904)
1. Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial.
Klein AL; Grimm RA; Jasper SE; Murray RD; Apperson-Hansen C; Lieber EA; Black IW; Davidoff R; Erbel R; Halperin JL; Orsinelli DA; Porter TR; Stoddard MF;
Am Heart J; 2006 Feb; 151(2):380-9. PubMed ID: 16442904
[TBL] [Abstract][Full Text] [Related]
2. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study.
Klein AL; Jasper SE; Katz WE; Malouf JF; Pape LA; Stoddard MF; Apperson-Hansen C; Lieber EA;
Eur Heart J; 2006 Dec; 27(23):2858-65. PubMed ID: 17098762
[TBL] [Abstract][Full Text] [Related]
3. Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation: ACUTE trial update.
Asher CR; Klein AL;
Card Electrophysiol Rev; 2003 Dec; 7(4):387-91. PubMed ID: 15071261
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
5. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation.
Saeed M; Rahman A; Afzal A; Agoston I; Jammula P; Birnbaum Y; Ware DL; Uretsky BF; Schwarz ER; Rosanio S
Int J Cardiol; 2006 Nov; 113(3):401-5. PubMed ID: 16822564
[TBL] [Abstract][Full Text] [Related]
6. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
Roijer A; Eskilsson J; Olsson B
Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
[TBL] [Abstract][Full Text] [Related]
7. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
Klein AL; Grimm RA; Murray RD; Apperson-Hansen C; Asinger RW; Black IW; Davidoff R; Erbel R; Halperin JL; Orsinelli DA; Porter TR; Stoddard MF;
N Engl J Med; 2001 May; 344(19):1411-20. PubMed ID: 11346805
[TBL] [Abstract][Full Text] [Related]
8. Design of a clinical trial for the assessment of cardioversion using transesophageal echocardiography (The ACUTE Multicenter Study). Steering and Publications Committees of the ACUTE Study.
Am J Cardiol; 1998 Apr; 81(7):877-83. PubMed ID: 9555778
[TBL] [Abstract][Full Text] [Related]
9. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M
G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
[TBL] [Abstract][Full Text] [Related]
11. Health status outcomes after cardioversion for atrial fibrillation: results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial.
Elliott DJ; Zhao L; Jasper SE; Lieber EA; Klein AL; Weintraub WS
Am Heart J; 2008 Aug; 156(2):374.e1-6. PubMed ID: 18657673
[TBL] [Abstract][Full Text] [Related]
12. Incidence of cerebral embolism after cardioversion of atrial fibrillation: a prospective study with transesophageal echocardiography and cerebral magnetic resonance imaging.
Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
J Am Soc Echocardiogr; 2005 Jun; 18(6):649-53. PubMed ID: 15947768
[TBL] [Abstract][Full Text] [Related]
13. Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography.
Klein AL; Grimm RA; Black IW; Leung DY; Chung MK; Vaughn SE; Murray RD; Miller DP; Arheart KL
Ann Intern Med; 1997 Feb; 126(3):200-9. PubMed ID: 9027270
[TBL] [Abstract][Full Text] [Related]
14. Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks.
Klein AL; Murray RD; Becker ER; Culler SD; Weintraub WS; Jasper SE; Lieber EA; Apperson-Hansen C; Heerey AM; Grimm RA;
J Am Coll Cardiol; 2004 Apr; 43(7):1217-24. PubMed ID: 15063433
[TBL] [Abstract][Full Text] [Related]
15. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
[TBL] [Abstract][Full Text] [Related]
16. Cost in the use of enoxaparin compared with unfractionated heparin in patients with atrial fibrillation undergoing a transesophageal echocardiography-guided cardioversion (from Assessment of Cardioversion using Transesophageal Echocardiography [ACUTE] II randomized multicenter study).
Zhao L; Zhang Z; Kolm P; Jasper S; Lewis C; Klein A; Weintraub W;
Am J Cardiol; 2008 Feb; 101(3):338-42. PubMed ID: 18237596
[TBL] [Abstract][Full Text] [Related]
17. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
[TBL] [Abstract][Full Text] [Related]
18. [Predictors of efficacy initial low energy of external rectilinear biphasic cardioversion in persistent atrial fibrillation].
Górecki AI; Stec S; Kucharska I; Wełnicki M; Zaborska B; Kryński T; Kułakowski P
Pol Merkur Lekarski; 2007 Dec; 23(138):408-12. PubMed ID: 18432122
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.
Hoppensteadt D; Fareed J; Klein AL; Jasper SE; Apperson-Hansen C; Lieber EA; Katz WE; Malouf JF; Stoddard MF; Pape LA;
Am J Cardiol; 2008 Oct; 102(7):842-6. PubMed ID: 18805108
[TBL] [Abstract][Full Text] [Related]
20. Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial.
Kozieł M; Merino JL; De Caterina R; Huber K; Jin J; Melino M; Goette A; Lip GYH;
Eur J Clin Invest; 2020 May; 50(5):e13221. PubMed ID: 32150758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]